Sun Pharma reports Q4 earnings.

◼️#US sales at $430 m, up 10.5% (YoY)

◼️Global #specialty sales at $244 m, Up 28% (YoY)

◼️India #formulation sales at Rs 3,364.1 cr, up 8.7% (YoY)

◼️Emerging Markets (#EMs) formulation #sales at $221 m, up 7.5% (YoY)

From Bloomberg | #MSCI #India index falls about 9%, MSCI Asia Pacific index & MSCI #EMs index also extend losses

#EMS lists at a premium of 33.67% to #IPO price on #NSE.

#EMS gets LoA from for Rs 140 crore project from #UttarakhandPowerCorp: Exchange filing

#EMS gets order worth Rs 140 crore from #Uttarakhand Power Corp.

#EMS' JV gets Rs 535 crore order from Uttarakhand Urban Sector Development Agency.

India set to beat #China in #EMs, largest weight in #MSCI EM index.

#JustIn | #EMS bags order worth ₹416.5 cr from #IndoreMunicipalCorporation

#EMS gets work order worth Rs 416 crore from Indore Municipal Corporation, has 26% share in order value with the other JV partner: Exchange filing